Robert Davis Noell - Mar 6, 2023 Form 4 Insider Report for DoubleVerify Holdings, Inc. (DV)

Signature
/s/ Sarah N. Conde, as Attorney-in-Fact for Robert Davis Noell
Stock symbol
DV
Transactions as of
Mar 6, 2023
Transactions value $
-$380,937,500
Form type
4
Date filed
3/8/2023, 07:14 PM
Previous filing
Nov 17, 2022
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DV Common Stock Sale -$329M -12.4M -18.51% $26.50 54.7M Mar 6, 2023 See footnotes F1, F2, F3, F4
transaction DV Common Stock Sale -$2.12M -80K -18.51% $26.50 352K Mar 6, 2023 By Providence Butternut Co-Investment L.P. F4, F5, F6, F7
transaction DV Common Stock Sale -$49.4M -1.86M -3.41% $26.50 52.8M Mar 6, 2023 See footnotes F2, F3, F4, F8
transaction DV Common Stock Sale -$318K -12K -3.41% $26.50 340K Mar 6, 2023 By Providence Butternut Co-Investment L.P. F4, F6, F7, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported represent shares of common stock of DoubleVerify Holdings, Inc. (the "Issuer") sold by Providence VII U.S. Holdings L.P. ("Providence VII") in an underwritten offering at a net price per share of $26.50.
F2 The securities reported are held directly by Providence VII and may be deemed to be beneficially owned by Providence Equity GP VII-A L.P. ("Providence GP") because Providence GP is the general partner of Providence VII. Jonathan M. Nelson, R. Davis Noell, J. David Phillips, Karim A. Tabet, Andrew A. Tisdale and Michael J. Dominguez control Providence Holdco (International) GP Ltd. ("Holdco"), which is the general partner of Providence Fund Holdco (International) L.P. Providence Fund Holdco (International) L.P. is the general partner of PEP VII-A International Ltd., which is the general partner of Providence GP.
F3 Jonathan M. Nelson, R. Davis Noell, J. David Phillips, Karim A. Tabet, Andrew A. Tisdale and Michael J. Dominguez may be deemed to exercise voting and investment power over, and thus may be deemed to beneficially own, the securities held by Providence VII due to their relationships with Holdco. R. Davis Noell hereby disclaims beneficial ownership of the shares held by Providence VII, except to the extent of his pecuniary interest therein, and this form shall not be construed as an admission that R. Davis Noell is the beneficial owner of any of the securities reported on this form.
F4 The record and other beneficial owners of the reported securities have separately filed Form 4s.
F5 The securities reported represent shares of common stock of the Issuer sold by Providence Butternut Co-Investment L.P. ("Providence Butternut") in an underwritten offering at a net price per share of $26.50.
F6 The securities reported are held directly by Providence Butternut and may be deemed to be beneficially owned by Providence GP because Providence GP is the general partner of Providence Butternut. Jonathan M. Nelson, R. Davis Noell, J. David Phillips, Karim A. Tabet, Andrew A. Tisdale and Michael J. Dominguez control Holdco, which is the general partner of Providence Fund Holdco (International) L.P. Providence Fund Holdco (International) L.P. is the general partner of PEP VII-A International Ltd., which is the general partner of Providence GP.
F7 Jonathan M. Nelson, R. Davis Noell, J. David Phillips, Karim A. Tabet, Andrew A. Tisdale and Michael J. Dominguez may be deemed to exercise voting and investment power over, and thus may be deemed to beneficially own, the securities held by Providence Butternut due to their relationships with Holdco. R. Davis Noell hereby disclaims beneficial ownership of the shares held by Providence Butternut, except to the extent of his pecuniary interest therein, and this form shall not be construed as an admission that R. Davis Noell is the beneficial owner of any of the securities reported on this form.
F8 The securities reported represent shares of common stock of the Issuer sold by Providence VII, after the underwriter's exercise of their option to purchase an additional 1,862,992 shares of the Issuer's common stock from Providence VII, in an underwritten offering at a net price per share of $26.50.
F9 The securities reported represent shares of common stock of the Issuer sold by Providence Butternut, after the underwriter's exercise of their option to purchase an additional 12,008 shares of the Issuer's common stock from Providence Butternut, in an underwritten offering at a net price per share of $26.50.